Impact of IFNL4 genetic variants on sustained virologic response and viremia in hepatitis C virus genotype 3 patients

Impact of IFNL4 genetic variants on sustained virologic response and viremia in hepatitis C virus genotype 3 patients

Hepatitis C virus (HCV) genotype 3 is very prevalent in Europe and Asia and is associated with worst outcomes than other genotypes. Genetic factors have been associated with HCV infection; however, no extensive genome-wide study has been performed among HCV genotype 3 patients. In this study, using...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser:	Pedergnana, V, Irving, W, Barnes, E, McLauchlan, J, Spencer, C
Format:	Journal article
Sprache:	English
Veröffentlicht:	Mary Ann Liebert 2019

Ähnliche Einträge

Impact of virus subtype and host IFNL4 genotype on large-scale RNA structure formation in the genome of hepatitis C virus
von: Simmonds, P, et al.
Veröffentlicht: (2020)

Impact of IFNL4 genotype on interferon-stimulated gene expression during daa therapy for Hepatitis C
von: Ramamurthy, N, et al.
Veröffentlicht: (2018)

Utility of a buccal swab point-of-care test for the IFNL4 genotype in the era of direct acting antivirals for hepatitis C virus
von: Sy, A, et al.
Veröffentlicht: (2023)

Utility of a buccal swab point-of-care test for the IFNL4 genotype in the era of direct acting antivirals for hepatitis C virus.
von: Aminata Sy, et al.
Veröffentlicht: (2023-01-01)

Donor IFNL4 Genotype Is Associated with Early Post-Transplant Fibrosis in Recipients with Hepatitis C.
von: Taylor Aiken, et al.
Veröffentlicht: (2016-01-01)

Hepatic Interferon-λ3 (IFNL3) Gene Expression Reveals Not to Be Attenuated in Non-Favorable IFNL3 rs4803217 or IFNL4 rs368234815 Minor Allele Carriers in Chronic Hepatitis C.
von: Ahmad Amanzada, et al.
Veröffentlicht: (2015-01-01)

Interferon lambda 4 variant rs12979860 is not associated with RAV NS5A Y93H in hepatitis C virus genotype 3a
von: Pedergnana, V, et al.
Veröffentlicht: (2016)

Association of HLA-DQ and IFNL4 polymorphisms with susceptibility to hepatitis B virus infection and clearance
von: Jia-Hao Fan, et al.
Veröffentlicht: (2016-07-01)

IFNL4 Genotypes Predict Clearance of RNA Viruses in Rwandan Children With Upper Respiratory Tract Infections
von: Belson Rugwizangoga, et al.
Veröffentlicht: (2019-10-01)

Nonsuppressible viremia during HIV-1 therapy meets molecular virology
von: Ann Emery, et al.
Veröffentlicht: (2023-03-01)

Genotyping and virological characteristics of hepatitis B virus in HIV-infected individuals in Sudan
von: Mukhlid Yousif, et al.
Veröffentlicht: (2014-12-01)

Association of IFNL3 gene rs4803217 with spontaneous clearance of Hepatitis C virus in patients from West Mexico
von: Andrea Y. Ochoa-Cervantes, et al.
Veröffentlicht: (2024-02-01)

Impact of PNPLA3 and IFNL3 polymorphisms on hepatic steatosis in Asian patients with chronic hepatitis C.
von: Chao-Min Huang, et al.
Veröffentlicht: (2017-01-01)

Viral genome wide association study identifies novel hepatitis C virus polymorphisms associated with sofosbuvir treatment failure
von: Smith, DA, et al.
Veröffentlicht: (2021)

COVID-19: Possible Impact of the Genetic Background in IFNL Genes on Disease Outcomes
von: Sabine Mihm
Veröffentlicht: (2020-04-01)

Immunological and virological characterization of HIV-1 viremia controllers in the North Region of Brazil
von: Samara Tatielle M. Gomes, et al.
Veröffentlicht: (2017-06-01)

IFNL4 ss469415590 Variant Is Associated with Treatment Response in Japanese HCV Genotype 1 Infected Individuals Treated with IFN-Including Regimens
von: Tatsuo Miyamura, et al.
Veröffentlicht: (2014-01-01)

Interferon lambda 4 impacts the genetic diversity of hepatitis C virus
von: Ansari, M, et al.
Veröffentlicht: (2019)

Interferon lambda 4 impacts the genetic diversity of hepatitis C virus
von: M Azim Ansari, et al.
Veröffentlicht: (2019-09-01)

Predictors of sustained virologic response in hepatitis C genotype 4 : beyond the usual suspects.
von: Abdo Ayman, et al.
Veröffentlicht: (2009-01-01)

The sustained virologic response of nonresponder hepatitis C virus patients with retreatment
von: Sila Cetin Akhan, et al.
Veröffentlicht: (2011-01-01)

Association of IFNL3 rs12979860 and rs8099917 with biochemical predictors of interferon responsiveness in chronic hepatitis C virus infection.
von: Janett Fischer, et al.
Veröffentlicht: (2013-01-01)

Amino acid substitutions in genotype 3a hepatitis C virus polymerase protein affect responses to sofosbuvir
von: Wing, P, et al.
Veröffentlicht: (2019)

IFNL4 and IFNL3 associated polymorphisms strongly influence the spontaneous IFN-alpha receptor-1 expression in HCV-infected patients.
von: Licia Bordi, et al.
Veröffentlicht: (2015-01-01)

IFNL4 genotype influences the rate of HIV-1 seroconversion in men who have sex with men
von: Giovanna Meza, et al.
Veröffentlicht: (2022-12-01)

Host genetic factors associated with hepatocellular carcinoma in patients with hepatitis C virus infection: A systematic review
von: Walker, A, et al.
Veröffentlicht: (2018)

Clinical and virological factors associated with viremia in pandemic influenza A/H1N1/2009 virus infection.
von: Herman Tse, et al.
Veröffentlicht: (2011-01-01)

Host and virological characteristics of patients with hepatitis C virus mixed genotype 1 and 2 infection
von: Chung-Feng Huang, et al.
Veröffentlicht: (2015-05-01)

The predictors of sustained virological response with sofosbuvir and ribavirin in patients with chronic hepatitis C genotype 2
von: Sung Yong Han, et al.
Veröffentlicht: (2021-05-01)

Rheumatic manifestations of hepatitis C virus infection are associated with autoantibodies but not viremia
von: Meng-Tzu Weng, et al.
Veröffentlicht: (2023-08-01)

Hepatitis C virus: virology and life cycle
von: Chang Wook Kim, et al.
Veröffentlicht: (2013-03-01)

Prevalence and genotype distribution of hepatitis C virus within hemodialysis units in Thailand: role of HCV core antigen in the assessment of viremia
von: Natthaya Chuaypen, et al.
Veröffentlicht: (2022-01-01)

Bocavirus Viremia and Hepatitis in an Immunocompetent Child
von: Zeliha Haytoğlu, et al.
Veröffentlicht: (2017-06-01)

No association between IFNL3 (IL28B) genotype and response to peginterferon alfa-2a in HBeAg-positive or -negative chronic hepatitis B.
von: Lai Wei, et al.
Veröffentlicht: (2018-01-01)

The dual-target approach in viral HIV-1 viremia testing: An added value to virological monitoring?
von: Alessandra Amendola, et al.
Veröffentlicht: (2020-01-01)

IFNL3 polymorphisms and HCV infection in patients with beta thalassemia
von: Raffaella Origa, et al.
Veröffentlicht: (2015-05-01)

The role of biochemical variations and genotype testing in determining the virological response of patients infected with hepatitis C virus
von: Abid Shoukat, et al.
Veröffentlicht: (2018-01-01)

Hepatitis C Genotypes in Libya: Correlation with Patients’ Characteristics, Level of Viremia, and Degree of Liver Fibrosis
von: Abdel-Naser Elzuoki, et al.
Veröffentlicht: (2017-09-01)

Hepatitis C virus: five-year follow-up of patients with sustained virological response
von: J. J. Urquijo, et al.

Correction: The dual-target approach in viral HIV-1 viremia testing: An added value to virological monitoring?
von: Alessandra Amendola, et al.
Veröffentlicht: (2020-01-01)